Literature DB >> 6191892

Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.

H Zola, P J McNamara, H A Moore, I J Smart, D A Brooks, I G Beckman, J Bradley.   

Abstract

The expression of six different membrane markers by cells of the human B lymphocyte lineage has been studied, using monoclonal antibodies. B cells representing various stages of differentiation/maturation have been examined, using normal cells, leukaemia cells, and continuous cell lines. The expression of the six markers has been compared with maturation stages defined by immunoglobulin expression. The HLA/beta 2-microglobulin complex is present throughout the B cell lineage, whilst the Ia (p28,33) marker is present from the earliest stage that can be attributed to the B lineage, but is lost during plasma cell differentiation. A marker detected by monoclonal antibody FMC 1 is present only on mature B lymphocytes, being absent from pre-B cells or plasma cells. FMC 7 detects an antigen found on a relatively mature subpopulation, whereas FMC 8 detects early as well as mature B cells. FMC 3 expression is found on a proportion of cells at any maturation stage, suggesting that expression of this marker is controlled by factors unrelated to maturation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191892      PMCID: PMC1536031     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Establishment and characterization of human B-lymphocytic lymphoma cell lines (BALM-3, -4 and -5); intraclonal variation in the B-cell differentiation stage.

Authors:  M S Lok; H Koshiba; T Han; S Abe; J Minowada; A A Sandberg
Journal:  Int J Cancer       Date:  1979-11-15       Impact factor: 7.396

2.  Recent progress in the immunological characterization of leukaemic cells.

Authors:  M F Greaves
Journal:  Blut       Date:  1977-05

3.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

4.  Prolymphocytic leukaemia.

Authors:  D A Galton; J M Goldman; E Wiltshaw; D Catovsky; K Henry; G J Goldenberg
Journal:  Br J Haematol       Date:  1974-05       Impact factor: 6.998

5.  Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development.

Authors:  J Halper; S M Fu; C Y Wang; R Winchester; H G Kunkel
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

6.  Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia.

Authors:  L B Vogler; W M Crist; D E Bockman; E R Pearl; A R Lawton; M D Cooper
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

7.  Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells.

Authors:  M A Moore; H E Broxmeyer; A P Sheridan; P A Meyers; N Jacobsen; R J Winchester
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

8.  Quantitation of human thymus-leukemia-associated antigen in established hematopoietic cell lines by radioimmunoassay.

Authors:  B E Chechik; J Minowada
Journal:  J Natl Cancer Inst       Date:  1979-09       Impact factor: 13.506

9.  B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states.

Authors:  E R Pearl; L B Vogler; A J Okos; W M Crist; A R Lawton; M D Cooper
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

10.  Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes.

Authors:  D A Brooks; I Beckman; J Bradley; P J McNamara; M E Thomas; H Zola
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

View more
  11 in total

1.  Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells.

Authors:  L K Ashman; G W Kriek; S J Cooper; D E O'Keefe
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Bone marrow histopathologic patterns and immunologic phenotype in B-cell chronic lymphocytic leukaemia.

Authors:  A Orfao; M Gonzalez; J San Miguel; A Rios; M D Caballero; M Sanz; M J Calmuntia; P Galindo; A Lopez Borrasca
Journal:  Blut       Date:  1988-07

3.  Phenotypical and functional analysis of B lymphocytes of two siblings with combined immunodeficiency and defective expression of major histocompatibility complex (MHC) class II antigens on mononuclear cells.

Authors:  G T Rijkers; J J Roord; F Koning; W Kuis; B J Zegers
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

Review 4.  Surface antigens associated with human B cell activation.

Authors:  L K Jung
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

5.  Immunoglobulin gene rearrangement and antigenic profile confirm B cell origin of primary cerebral lymphoma and indicate a mature phenotype.

Authors:  W J Smith; J A Garson; S P Bourne; J T Kemshead; H B Coakham
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

6.  Evaluation of CD5-positive B cells in blood and synovial fluid of patients with rheumatic diseases.

Authors:  J A Sowden; P J Roberts-Thomson; H Zola
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

7.  Mitogenic response of neoplastic B cells: comparison of reactivity to Staphylococcus aureus Cowan I and anti-immunoglobulin antibodies.

Authors:  T Tamaki; T Yonezawa; Y Kanakura; S Katagiri; H Mizutani; T Kitani; S Tarui
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

8.  Responses of 'mature' human B lymphocyte lines to inducers of maturation and activation.

Authors:  H Zola; V Griffith; I Hunter; L Koh; J Bradley
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

9.  Immunopathology of non-Hodgkin lymphomas.

Authors:  H Huber; C Gattringer; W Knapp; H Stein
Journal:  Klin Wochenschr       Date:  1984-11-02

10.  Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.

Authors:  R A Jones; S J Richards; D Patel; C S Scott
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.